AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Indaptus Therapeutics, Inc. Director's Dealing 2022

Dec 20, 2022

Director's Dealing

Opens in your device viewer

Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2022-01-31

Reporting Person: Litchev Boyan Vesselinov (Chief Medical Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-31	Common Stock	P	100	$4.65	Acquired	100	Direct
2022-03-02	Common Stock	P	50	$4.0926	Acquired	150	Direct
2022-11-22	Common Stock	P	500	$1.83	Acquired	650	Direct
2022-12-01	Common Stock	P	500	$1.8709	Acquired	1150	Direct